Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Following the March 2026 grant of FTD to PLX-200 in treatment of Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL/CLN2 disease), PLX-200 now holds FTD for all four prospective indications to be ...
Bored Panda on MSN

53 stories about weaponized incompetence that might break your heart

Claiming “I can’t do it” can be a harmless excuse, until it’s used strategically. Some adults have mastered this tactic to ...
eLife

Audiovisual congruency drives confidence in presence and absence

Detection decisions (red for absence, blue for presence) are based on the disjunctive integration rule (disjunction and negation of disjunction). Confidence decisions (dashed line for not sure, full ...
HUB

For Media

Studying the star, called SDSS J0715-7334, could give astronomers insights into how the universe's first stars were formed ...